In concert with downregulated PI3K/Akt/mTOR signaling, ISO has been previously reported to increase the expression and activity of FOXO1 and FOXO3a in bladder cancer cells [18,19,37]. The gene discussed is FOXO1; the disease is urinary bladder carcinoma.